CB1-IN-3 (Compound 6i) is a potent inhibitor of the cannabinoid receptor type 1 (CB1). It holds potential for research in obesity, inflammation, and neurological disorders.
Target:
Cannabinoid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
